| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2021 | NATIONAL BIOMEDICAL, LLC | 861 E HENNEPIN AVE STE 430 | MINNEAPOLIS | MN | 55414-4496 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 000 | 3 | NIH | 12/29/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | NATIONAL BIOMEDICAL, LLC | 861 E HENNEPIN AVE STE 430 | MINNEAPOLIS | MN | 55414-4496 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 6 | NIH | 10/26/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,649,847 ) |
| | 2023 | 2023 | NATIONAL BIOMEDICAL LLC | 861 E HENNEPIN AVE | MINNEAPOLIS | MN | 55414-4496 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 003 | 6 | NIH | 9/7/2023 | $998,941 |
| | 2023 | 2021 | NATIONAL BIOMEDICAL LLC | 861 E HENNEPIN AVE | MINNEAPOLIS | MN | 55414-4496 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 003 | 3 | NIH | 9/7/2023 | $650,906 |
|
|
